1887

oa South African Journal of Bioethics and Law - Transparency in medicines regulatory affairs – reclaiming missed opportunities

Volume 10 Number 2
  • ISSN : 1999-7639

 

Abstract

Transparency is a salutary value in South Africa (SA)’s constitutional architecture. It has also been described as a necessary element in promoting accountability in the regulatory aspects of essential medicines. Nevertheless, despite its several incarnations since its promulgation, the Medicines and Related Substances Act No. 101 of 1965 retains a ‘preservation of secrecy’ provision (section 34). This contribution seeks to evaluate section 34 in the context of transparency; to ascertain whether it is in conflict with other legislation pertaining to the promotion of access to information; and, in particular, to establish whether it is consistent with the Constitution of the Republic of SA.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/journal/10520/EJC-c8a20f3bd
2017-12-01
2018-12-10

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error